Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Rob, and I'll be your conference call operator today. At this time, all participants are in listen-only mode.
Puma Biotechnology Inc. (PBYI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 2,880,888 | $7,346,264 | -9% | 0% |
| 2. | Renaissance Technologies Jim Simons | 1,772,413 | $4,519,653 | +2% | 0% |
| 3. | Eversept Partners Kamran Moghtaderi | 1,293,257 | $3,297,805 | -3% | 0.22% |
| 4. | Winton Capital Management David Harding | 308,980 | $787,899 | +3% | 0.05% |
| 5. | Tang Capital Management Kevin C. Tang | 200,000 | $510,000 | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.49 | 28 | Officer | 30 | 2014-04-11 | Filing | |
| $87.35 | 2 | Officer | 2 | 2014-04-09 | Filing | |
| $38.92 | 22,549 | Large Shareholder | 5,686,668 | 2013-11-08 | Filing | |
| $39.60 | 280,700 | Large Shareholder | 5,664,119 | 2013-11-05 | Filing | |
| $40.08 | 54,200 | Large Shareholder | 5,383,419 | 2013-10-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.49 | 23,358 | Director | 47,000 | 2024-08-12 | Filing | |
| $3.70 | 4,156 | Officer | 162,522 | 2024-07-17 | Filing | |
| $3.70 | 2,598 | Officer | 118,388 | 2024-07-17 | Filing | |
| $3.70 | 3,637 | Officer | 133,227 | 2024-07-17 | Filing | |
| $3.70 | 21,920 | Large Shareholder, Officer, Director | 7,063,515 | 2024-07-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,802,081 | $16,463,011 | 0% | |
| 2. | 1,792,114 | $7,759,854 | 11.27% | |
| 3. | 1,544,532 | $6,687,824 | 0% | |
| 4. | 538,559 | $2,331,960 | 0.23% | |
| 5. | 497,722 | $2,155,270 | 0% |
News See All
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Diego and I will be your conference call operator today. [Operator Instructions] As a reminder, this conference call is being recorded.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript
Puma Biotechnology, Inc. misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.37. Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Camilla, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded.
5 Best Quality Penny Stocks to Buy
Chimerix, Inc. (NASDAQ:CMRX) is working on treatments for fatal diseases. Chimerix, Inc.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Victoria, and I will be your conference call operator today. At this time, all participants are in a listen-only mode.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Rob, and I will be your conference call operator today. As a reminder, this call is being recorded.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. My name is Diego, and I will be your conference call operator today. As a reminder, this call is being recorded.
5 Most Promising Cancer Stocks According to Analysts
BeiGene, Ltd. (NASDAQ:BGNE) is a Massachusetts-based biotechnology company that focuses on discovering, developing, and commercializing medicines worldwide.